Skip to main content

MannKind Corp (MNKD) Stock

MannKind Corp Stock Details, Movements and Public Alerts

Stock Details

MannKind Corp (MNKD), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $5.84. Over the past 52 weeks, it has ranged between $3.38 and $7.04. This places the current price at 83.0% of its 52-week high and 72.8% above its 52-week low. Recent trading volume was recorded at 13,714,194. The 14-day Relative Strength Index (RSI) stands at 59.72, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $5.46 by 6.96%. Similarly, it is above its 200-day moving average of $4.77 by 22.43%. The MACD histogram is 0.02, indicating bullish momentum (MACD Line: 0.16, Signal Line: 0.14). There is currently 1 active alert set for MNKD by users.

52-Week Range

$7.04 - $3.38

-17.05% from high · +72.78% from low

Avg Daily Volume

3,374,685

20-day average

100-day avg: 4,318,181

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

50.70

Above market average

Forward P/E

84.75

Earnings expected to decline

PEG Ratio

-0.23

Potentially undervalued

EV/EBITDA

23.01

EPS (TTM)

$0.10

Price to Sales

5.81

Beta

0.81

Less volatile than market

Q:How is MNKD valued relative to its earnings and growth?
MannKind Corp trades at a P/E ratio of 50.70, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 84.75 is higher than the current P/E, indicating analysts expect earnings to decline over the next year. The PEG ratio of -0.23 suggests the stock may be undervalued relative to its growth rate.
Q:What is MNKD's risk profile compared to the market?
With a beta of 0.81, MannKind Corp is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability.

Performance & Growth

Profit Margin

9.32%

Operating Margin

22.90%

EBITDA

$84.72M

Return on Equity

0.00%

Return on Assets

9.95%

Revenue Growth (YoY)

17.20%

Earnings Growth (YoY)

-34.90%

Q:How profitable and efficient is MNKD's business model?
MannKind Corp achieves a profit margin of 9.32%, meaning it retains $9.32 from every $100 in revenue after all expenses. This represents a solid margin typical of well-run businesses, showing the company can effectively balance revenue generation with cost control. The operating margin of 22.90% reveals how efficiently the company runs its core business operations before interest and taxes.0
Q:What are MNKD's recent growth trends?
MannKind Corp's revenue grew by 17.20% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings decreased by 34.90% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Market Cap

$1.6B

Revenue (TTM)

$313.79M

Revenue/Share (TTM)

$1.05

Shares Outstanding

307.07M

Book Value/Share

-$0.15

Asset Type

Common Stock

Q:What is MNKD's market capitalization and position?
MannKind Corp has a market capitalization of $1.6B, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 307.07M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does MNKD's price compare to its book value?
MannKind Corp's book value per share is -$0.15, while the current stock price is $5.84, resulting in a price-to-book (P/B) ratio of -40.28. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$9.44

61.64% upside potential

Analyst Recommendations

Strong Buy

1

Buy

8

Hold

0

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for MNKD?
9 analysts cover MNKD with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $9.44 implies 61.6% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on MNKD?
Current analyst recommendations:1 Strong Buy, 8 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Dec 14, 2025, 02:09 AM

Technical Indicators

RSI (14-day)

59.72

Neutral

50-Day Moving Average

$5.46

6.96% above MA-50

200-Day Moving Average

$4.77

22.43% above MA-200

MACD Line

0.16

MACD Signal

0.14

MACD Histogram

0.02

Bullish

Q:What does MNKD's RSI value tell investors?
The RSI (Relative Strength Index) for MNKD is currently 59.72, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret MNKD's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.16 above the signal line at 0.14, with histogram at 0.02. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($5.46) is above the 200-day MA ($4.77), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Dec 20, 2025, 12:45 AM

Active Alerts

Alert Condition
Price falls below
Threshold
$4.74
Created
Nov 28, 2025, 05:17 PM

Stay Ahead of the Market with MannKind Corp Alerts

Set up price alerts for MannKind Corp and get notified instantly when the price hits your target. Never miss an important price movement again.